Phage Therapy: A Promising Solution in the Battle Against Superbugs.

Antimicrobial resistance (AMR), or the rise of “superbugs,” is a pressing global health concern. Bacteriophages, or phages, are viruses that target and infect bacteria, making them a potential long-term solution against evolving and resistant bacteria. Phage therapy has been used for over a century to treat bacterial infections, and recent cases have been used to combat drug-resistant infections like MRSA. Westmead Health Precinct is actively addressing challenges in matching appropriate phages and ensuring the safety and effectiveness of phage products. Phage Australia has co-founded the program, integrating it into clinical services. Since December 2021, patients in Australia have gained access to bacteriophage therapy through the Therapeutic Goods Administration Special Access Scheme, under the STAMP protocol. This progress highlights the potential of phage therapy as an alternative approach to combating AMR and treating difficult-to-treat infections.